BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Veristat Presents Integrated, Customized DCT Solutions at the DTRA Annual Meeting

  Offering integrated solutions for the implementation of decentralized clinical trials (DCTs), Veristat presented the advantages of its flexible and fully customized service delivery model at the Decentralized Trials Research Alliance (DTRA) annual meeting, which took place last month in Boston.

  December 13, 2022

   · 

  3 min read
• AB Science receives Notice of Deficiency (NOD) from Health Canada for masitinib in the treatment of amyotrophic lateral sclerosis (ALS)

  AB Science SA (Euronext - FR0010557264 - AB) today announced that it has received a Notice of Deficiency (“NOD”) for its masitinib New Drug Submission in the treatment of amyotrophic lateral sclerosis.

  December 13, 2022

   · 

  3 min read
• BioCapital

  Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Litigation

  Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today responded to the ruling in its HETLIOZ® ANDA Litigation.

  December 13, 2022

   · 

  3 min read
• SK Biopharmaceuticals Unveils Vision for Digital Healthcare

  SK Biopharmaceuticals, an innovative global pharmaceutical company, held a media briefing to introduce its roadmap and vision for its digital healthcare business in Seoul, Korea, ahead of CES 2023, January 5-8 in Las Vegas.

  December 13, 2022

   · 

  2 min read